Crystal Pharmatech is set to join ChemOutsourcing 2022, the most extensive USA-based API and pharmaceutical ingredients show. From September 7-9 at the Hilton Hotel, Parsippany, New Jersey, Crystal Pharmatech will participate in various activities and discussions tackling the future of pharma, particularly the API development supply chain. The company's willingness to meet industry players, buyers, and suppliers to share knowledge, learn from other's experiences, and push for innovation is a significant step towards continuous growth.
The event will allow exhibitors to showcase their services and meet their customers at their respective booths when Crystal Pharmatech celebrates its 12th anniversary. At Booth #72, attendees will have a chance to learn about Crystal Pharmatech's services and work in API Form and Solid-State Research, Formulation Development, and Clinical & Commerical Manufacturing.
One of the highlights for Crystal Pharmatech will be the recently opened Crystal Formulation Services (CFS), a novel, small molecule and formulation CDMO located in Suzhou, China. Through CFS, the company aims to expand its capability in oral solid formulation technology for NCE drug product development and to provide comprehensive solutions to biotechs and pharmaceutical companies. In addition, a GMP manufacturing plant is set to operate by the end of September. While CFS is based in China, biotechs will have a North American choice in Candoo Pharmatech as it partners with Crystal Pharmatech in formulation development.
Robert Wenslow, Ph.D., Crystal Pharmatech's Vice President of Business Development, will be part of ChemOutsourcing's panel discussion on "Choosing the Right CDMO for Biotechs: Past, Present, and Future" on September 7. At the event, he will be joined by Crystal Pharmatech senior scientist Mitul Patel and Head of Marketing Mailisi Heshuote. Wenslow, who will be available for meetups on September 8, has said recently, "I'm excited to meet like-minded individuals at the event and to learn from each other, hear their stories and experiences, and share our vision in advancing solid-state research and formulation." On September 9, Mitul will be available to meet with attendees and answer any questions about Crystal Pharmatech's services and developments.
Geared towards unique sourcing needs, ChemOutsourcing 2022 is expected to attract up to 700 attendees from the pharmaceutical, biotech, and chemistry service industries from 30 countries. The avenue it will open for knowledge-sharing and networking is a platform that Crystal Pharmatech aims to utilize to reach out to innovators in need of assistance in their drug development journey. "We are committed to becoming a trusted partner for high-quality solid-state research and formulation. Knowing them and their needs is a priority to continue enhancing our services and capabilities," said Winslow.
For more information on Crystal Pharmatech's ChemOutsourcing activities, check their updates on their LinkedIn page.